Tuberculosis (TB) is a major infectious disease killing nearly two million people, mostly in
developing countries, every year. The increasing incidence of resistance of Mycobacterium …

Currently, one third of the world's population is latently infected with Mycobacterium
tuberculosis (MTB), while 8.9–9.9 million new and relapse cases of tuberculosis (TB) are …

Tuberculosis is an ever-changing field. The editors and authors of “Tuberculosis 2007–from
basic science to patient care” have made every effort to provide information that is accurate …

A microplate-based rapid, inexpensive and robust technique is developed by using
tetrazolium salt 2, 3-bis [2-methyloxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide …

Tuberculosis (TB) is a health public problem and a long combination therapy is necessary to
treat patients. In recent years, some drugs, not routinely used in treatment of TB, have …

Despite of the advances made in the treatment and management, tuberculosis (TB) still
remains one of main public health problem. The contrary effects of first and second-line anti …

A rapid fluorescent viability assay employing alamarBlue was optimized for use with
Leishmania axenic amastigotes, the stage of the parasite responsible for disease pathology …

Multidrug-resistant and extensively drug-resistant tuberculo... : Current Opinion in Infectious
Diseases Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the …

Tuberculosis still represents a major public health problem, especially in low-resource
countries where the burden of the disease is more important. Multidrug-resistant and …

This review describes the methods available for drug susceptibility testing of Mycobacterium
tuberculosis. The methods have been developed over several decades and are restricted to …